New lycorine-type alkaloid from Lycoris traubii and evaluation of antitrypanosomal and antimalarial activities of lycorine derivatives
A new lycorine derivative LT1 ( 4) was isolated from the Lycoris traubii Hayward (Amaryllidaceae). Some lycorine ester derivatives were examined for their inhibitory activity against trypanosoma and against malaria in vitro. Among them, 6 showed potent activity against trypanosoma and 4, 8, 11, and...
Saved in:
Published in | Bioorganic & medicinal chemistry Vol. 16; no. 24; pp. 10182 - 10189 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier Ltd
15.12.2008
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A new lycorine derivative LT1 (
4) was isolated from the
Lycoris traubii Hayward (Amaryllidaceae). Some lycorine ester derivatives were examined for their inhibitory activity against trypanosoma and against malaria in vitro. Among them,
6 showed potent activity against trypanosoma and
4,
8,
11, and
12 showed significant activity against malaria.
A new lycorine derivative LT1 (
4) was isolated from the aerial part and bulbs of
Lycoris traubii Hayward (Amaryllidaceae). Its structure including absolute configuration was established by spectroscopic analysis and semi-synthesis to be 1-
O-(3′
S)-hydroxybutanoyllycorine. Some lycorine ester derivatives including LT1 were examined for their inhibitory activity against
Trypanosoma brucei brucei, the parasite associated with sleeping sickness, and against
Plasmodium falciparum, the causative agent of malaria. Among them, 2-
O-acetyllycorine (
6) showed the most potent activity against parasitic
T. b. brucei, and LT1 (
4), 1-
O-(3′
R)-hydroxybutanoyllycorine (
8), 1,2-di-
O-butanoyllycorine (
11), and 1-
O-propanoyllycorine (
12) showed significant activity against
P. falciparum in an in vitro experiment. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2008.10.061 |